University of Perugia researcher to lead BioNanoFilter European clinical trial on Group B Strep

Links shared publicly online about this topic.

236
total visits

University of Perugia researcher to lead BioNanoFilter European clinical trial on Group B Strep

NanoLogix, a biotechnology innovator in the rapid detection and identification of live-cell bacteria and microorganisms, announced today its BioNanoFilter (BNF) technology will undergo a clinical trial, led by Dr. Gian Carlo Di Renzo of the University of Perugia in Italy.

View full resource at news-medical.net

Tags: Group B Strep, Meningitis, Strep Throat, Clinical Trial, Biotech, News